Suppose The recent merger of two major pharmaceutical companies has created concerns about potential monopolistic practices in the industry. Many have expressed worries that this merger will lead to higher prices for important medications and reduced competition in the market.
Can we infer that "the merger will lead to lower drug prices"? Yes, no, or maybe?